CNS myelination and PLP gene dosage

Pharmacogenomics

Volumn 2, Issue 3, 2001, Pages 263-272

  Woodward, K ^a   Malcolm, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CNS dysmyelination; Duplication; Gene dosage; Pelizaeus Merzbacher disease; PLP; Proteolipid protein; Spastic paraplegia Type 2

Indexed keywords

AMINO ACID; DNA; ISOPROTEIN; MEMBRANE PROTEIN; MYELIN PROTEIN; NERVE PROTEIN; PROTEOLIPID PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CENTRAL NERVOUS SYSTEM; CHROMOSOME DUPLICATION; CHROMOSOME XQ; CONTROLLED STUDY; DNA DETERMINATION; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GENE DELETION; GENE DOSAGE; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENE TECHNOLOGY; GENE THERAPY; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC PROCEDURES; GENETIC SCREENING; HAPLOIDY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN EXPERIMENT; MALE; MOUSE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PHARMACOGENOMICS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVIEW; SEQUENCE ANALYSIS; SPASTIC PARAPLEGIA;

ANIMALS; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; HUMANS; MUTATION; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; PELIZAEUS-MERZBACHER DISEASE; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 0034846511     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.2.3.263     Document Type: Review

References (77)

1. Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits
2. Current concepts of PLP and its role in the nervous system
3. Molecular cloning of M6: Identification of a PLP/DM20 gene family
4. Expression of members of the proteolipid protein gene family in the developing murine central nervous system
5. A proteolipid protein gene family: Expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide
6. Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin
7. Evolution of the myelin integral membrane proteins of the central nervous system
8. Proteolipid protein (PLP) of CNS myelin: Positions of free, disulfide-bonded and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP
9. The gene encoding for the major brain proteolipid (PLP) maps on the q-22 band of the human X chromosome
10. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin
11. A proteolipid protein-specific pre-mRNA (Ppm-1) contains intron 3 and is up-regulated during myelination in the CNS
12. Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons
13. The pathobiology of myelin mutants reveal novel biological functions of the MBP and PLP genes
14. The molecular pathogenesis of Pelizaeus-Merzbacher disease
15. Genetics of Pelizaeus-Merzbacher disease
16. Mutation of the proteolipid protein gene PLP in a human X chromosome- linked myelin disorder
17. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus
18. 169 Phe) in exon 4 of the proteolipid protein gene (PLP)
19. Genetic homogeneity of Pelizaeus-Merzbacher disease: Tight linkage to the proteolipoprotein locus in 16 affected families
20. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease
21. Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease
22. Pelizaeus-Merzbacher disease: Identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH
23. Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: Molecular mechanism and phenotypic manifestations
24. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease
25. A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family
26. Proteolipid protein is necessary in peripheral as well as central myelin
27. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations
28. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease Type 1A duplication
29. DNA duplication associated with Charcot-Marie-Tooth disease Type 1A
30. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17
31. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease Type 1A
32. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene
33. A G to T mutation at a splice site in a case of Pelizaeus-Merzbacher disease
34. Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease
35. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport
36. A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease
37. Phenotypic severity of murine PLP mutants reflects in vivo and in vitro variations in transport of PLP isoproteins
38. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease
39. The early phenotype associated with the jimpy mutation of the proteolipid protein gene
40. Jimpy mutant mouse: A 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing
41. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein
42. The proteolipid protein gene and myelin disorders in man and animal models
43. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene
44. Conservative amino acid substitution in the myelin proteolipid protein of jimpy msd mice
45. 75-Pro) of the myelin proteolipid protein causes dysmyelination and oligodendrocyte death
46. A point mutation in the proteolipid protein gene of the 'shaking pup' interrupts oligodendrocyte development
47. Paralytic tremor (pt): A new allele of the proteolipid protein gene in rabbits
48. The rumpshaker mutation in spastic paraplegia
49. Jimpy(msd) mouse mutation and connatal Pelizaeus-Merzbacher disease
50. Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice
51. Assembly of CNS myelin in the absence of proteolipid protein
52. Myelin proteolipid proteins promote the interaction of oligodendrocytes and axons
53. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin
54. The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin
55. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage
56. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene
57. Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage
58. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene
59. Prenatal diagnosis by FISH in a family with Pelizaeus-Merzbacher disease caused by duplication of PLP gene
60. A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR
61. Duplication of proteolipid protein gene: A possible major cause of Pelizaeus-Merzbacher disease
62. A new polymorphism in the proteolipid protein (PLP1) gene and its use for carrier detection of PLP1 gene duplication in Pelizaeus-Merzbacher disease
63. Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome
64. Proteolipo-protein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: Duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not
65. Breaking away from home
66. Charcot-Marie-Tooth Type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit
67. The human COX10 gene is disrupted during homologous recombination between the 24 kb proximal and distal CMT1A-REPs
68. Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy Type 1a (CMT1a)
69. Large genomic duplicons map to sites of instability in the Prader-Willi/Angelman syndrome chromosome region (15q11-q13)
70. Masquerading repeats: Paralogous pitfalls of the human genome
71. Repair of myelin disease: Strategies and progress in animal models
72. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin
73. Charcot-Marie-Tooth neuropathy Type 1A mutation: Apparent crossovers with D17S122 are due to a duplication
74. Initial sequencing and analysis of the human genome
75. Structure of chromosomal duplicons and their role in mediating human genomic disorders
76. Pathological consequences of sequence duplications in the human genome
77. Olfactory receptor-gene clusters, genomic-inversion polymorphisms and common chromosome rearrangements